Diabetes Clinical Trials in Raleigh, NC

55 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)	Phase 1/2	COUR Pharmaceutical Development Company, Inc.	<1 mi
A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)	Phase 3	Pfizer	<1 mi
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	<1 mi
Assessment of AI Program 'DRISTi' as a Screening Tool	—	Artelus AI	<1 mi
A Food As Medicine Approach to Address Food Insecurity in Rural North Carolina	N/A	North Carolina State University	<1 mi
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM	Phase 3	AstraZeneca	<1 mi
Matrion Decellularized Placental Membrane Versus Conventional Wound Management in Subjects With Diabetic Foot Ulcers	N/A	LifeNet Health	<1 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes	Phase 3	Novo Nordisk A/S	<1 mi
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers	N/A	Tides Medical	<1 mi
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL	Phase 4	HealthTech Wound Care	<1 mi
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus	Phase 3	AstraZeneca	<1 mi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin	Phase 3	AstraZeneca	<1 mi
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus	Phase 2	Corxel Pharmaceuticals	<1 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)	Phase 2/3	CSL Behring	<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	8 mi
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes	Phase 3	Kailera	11 mi
Personalized Environment and Genes Study	—	National Institute of Environmental Health Sciences (NIEHS)	15 mi
A Study of GNTI-122 in Adults Recently Diagnosed With T1D	Phase 1	GentiBio, Inc	21 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	21 mi
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers	Phase 2	Zhuhai Rui-Inno Pharmaceutical Technology Co., Ltd.	21 mi
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)	N/A	Duke University	21 mi
Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US	—	Duke University	21 mi
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes	Phase 4	Brigham and Women's Hospital	21 mi
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes	N/A	Duke University	21 mi
A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome	Phase 3	NewAmsterdam Pharma	21 mi
Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance.	Phase 1	David D'Alessio, M.D.	21 mi
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)	N/A	Duke University	21 mi
Intraoperative OCT Guidance of Intraocular Surgery II	—	Duke University	21 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	21 mi
CGM for Management of Type 2 Diabetes in Pregnancy	N/A	University of Alabama at Birmingham	25 mi
Food as Medicine for HIV and Diabetes	N/A	University of North Carolina, Chapel Hill	25 mi
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	N/A	Piomic Medical	25 mi
SPYRAL GEMINI Pilot Study	N/A	Medtronic Vascular	25 mi
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes	N/A	UNC Lineberger Comprehensive Cancer Center	25 mi
Kidney Precision Medicine Project	—	Icahn School of Medicine at Mount Sinai	25 mi
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes	Phase 3	vTv Therapeutics	25 mi
Transformative Research in Diabetic Nephropathy	—	University of Pennsylvania	25 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	25 mi
REAL-Fam Feasibility Study for Youth Diabetes Management	N/A	University of North Carolina, Chapel Hill	25 mi
Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART	N/A	University of North Carolina, Chapel Hill	25 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)	Phase 2	Sparrow Pharmaceuticals	25 mi
Registry for Stage 2 Type 1 Diabetes	—	Sanofi	25 mi
HLA Demographics Study in Adults With Type 1 Diabetes	—	GentiBio, Inc	25 mi
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes	Phase 4	Ohio State University	25 mi
Rare and Atypical Diabetes Network	—	University of South Florida	25 mi
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes	Phase 2	SAb Biotherapeutics, Inc.	25 mi
Preventing Type 2 Diabetes in Black Emergent Adult	N/A	University of North Carolina, Chapel Hill	25 mi
Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine	N/A	University of North Carolina, Chapel Hill	25 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin	Phase 3	Eli Lilly and Company	25 mi
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease	Phase 3	Prokidney	25 mi
A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and Effectiveness for Proximal Intestinal Mucosal Ablation in Patients With Type 2 Diabetes Mellitus (RESTORE-1 Study)	N/A	Aqua Medical, Inc.	25 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)	Phase 3	Eli Lilly and Company	25 mi
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)	N/A	University of North Carolina, Chapel Hill	25 mi
Healthy Living Anson Study	N/A	University of North Carolina, Chapel Hill	25 mi
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)	Phase 4	Cellution Biologics	49 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.